Inventor · disambiguated record
Nebojsa Janjic
Also filed as: JANJIC NEBOJSA
70 granted patents·31 pending applications·3,804 citations·filing 1994–2024
99Inventor score
Files withSOMALOGIC INC30GILEAD SCIENCES INC26NEXSTAR PHARMACEUTICALS INC17SOMALOGIC OPERATING CO INC8CRESTONE INC3
Top patents by PatentIndex Score
101 records- 0198US5958691AHigh affinity nucleic acid ligands containing modified nucleotidesNEXSTAR PHARMACEUTICALS INC·Filed 1997·Granted Sep 28, 1999·379 cites·24 claims
- 0298US5660985AHigh affinity nucleic acid ligands containing modified nucleotidesNEXSTAR PHARMACEUTICALS INC·Filed 1995·Granted Aug 26, 1997·534 cites·10 claims
- 0397US10239908B2Cytidine-5-carboxamide modified nucleotide compositions and methods related theretoSOMALOGIC INC·Filed 2018·Granted Mar 26, 2019·37 cites·13 claims
- 0497US10221421B2Post-selec modification methodsSOMALOGIC INC·Filed 2017·Granted Mar 5, 2019·39 cites·6 claims
- 0597US6465188B1Nucleic acid ligand complexesGILEAD SCIENCES INC·Filed 2000·Granted Oct 15, 2002·63 cites·17 claims
- 0697US6168778B1Vascular endothelial growth factor (VEGF) Nucleic Acid Ligand ComplexesNEXSTAR PHARMACEUTICALS INC·Filed 1997·Granted Jan 2, 2001·244 cites·35 claims
- 0797US6051698AVascular endothelial growth factor (VEGF) nucleic acid ligand complexesFiled 1997·Granted Apr 18, 2000·294 cites·21 claims
- 0897US6011020ANucleic acid ligand complexesNEXSTAR PHARMACEUTICALS INC·Filed 1995·Granted Jan 4, 2000·395 cites·24 claims
- 0996US10392621B2Multiaptamer target detectionSOMALOGIC INC·Filed 2018·Granted Aug 27, 2019·36 cites·35 claims
- 1096US10221207B25-position modified pyrimidines and their useSOMALOGIC INC·Filed 2017·Granted Mar 5, 2019·39 cites·3 claims
- 1195US9926566B2Multiaptamer target detectionSOMALOGIC INC·Filed 2014·Granted Mar 27, 2018·38 cites·18 claims
- 1295US9163056B25-position modified pyrimidines and their useSOMALOGIC INC·Filed 2013·Granted Oct 20, 2015·42 cites·3 claims
- 1395US6229002B1Platelet derived growth factor (PDGF) nucleic acid ligand complexesNEXSTAR PHARMACEUTICLAS INC·Filed 1997·Granted May 8, 2001·115 cites·11 claims
- 1494US9938314B2Cytidine-5-carboxamide modified nucleotide compositions and methods related theretoSOMALOGIC INC·Filed 2014·Granted Apr 10, 2018·38 cites·13 claims
- 1594US5811533AHigh-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)NEXSTAR PHARMACEUTICALS INC·Filed 1995·Granted Sep 22, 1998·121 cites·18 claims
- 1693US6582918B2Platelet derived growth factor (PDGF) nucleic acid ligand complexesGILEAD SCIENCES INC·Filed 2001·Granted Jun 24, 2003·37 cites·37 claims
- 1793US6184364B1High affinity nucleic acid ligands containing modified nucleotidesNEXSTAR PHARMACEUTICALS INC·Filed 1999·Granted Feb 6, 2001·97 cites·2 claims
- 1892US6147204ANucleic acid ligand complexesNEXSTAR PHARMACEUTICALS INC·Filed 1996·Granted Nov 14, 2000·209 cites·39 claims
- 1992US5459015AHigh-affinity RNA ligands of basic fibroblast growth factorNEXSTAR PHARMACEUTICALS INC·Filed 1994·Granted Oct 17, 1995·144 cites·6 claims
- 2091US7939654B2Platelet derived growth factor (PDGF) nucleic acid ligand complexesGILEAD SCIENCES INC·Filed 2009·Granted May 10, 2011·10 cites·26 claims
- 2191US7879993B2Platelet derived growth factor (PDGF) nucleic acid ligand complexesGILEAD SCIENCES INC·Filed 2007·Granted Feb 1, 2011·11 cites·1 claims
- 2291US5674685AHigh affinity PDGF nucleic acid ligandsNEXSTAR PHARMACEUTICALS INC·Filed 1995·Granted Oct 7, 1997·102 cites·7 claims
- 2391US5668264AHigh affinity PDGF nucleic acid ligandsNEXSTAR PHARMACEUTICALS INC·Filed 1995·Granted Sep 16, 1997·95 cites·7 claims
- 2490US5859228AVascular endothelial growth factor (VEGF) nucleic acid ligand complexesNEXSTAR PHARMACEUTICALS INC·Filed 1996·Granted Jan 12, 1999·83 cites·7 claims
- 2589US6426335B1Vascular endothelial growth factor (VEGF) nucleic acid ligand complexesGILEAD SCIENCES INC·Filed 1997·Granted Jul 30, 2002·73 cites·23 claims
- 2689US6329145B1Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligandGILEAD SCIENCE INC·Filed 1999·Granted Dec 11, 2001·73 cites·10 claims
- 2786US9701967B2Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditionsSOMALOGIC INC·Filed 2016·Granted Jul 11, 2017·4 cites·10 claims
- 2886US9081010B2Aptamers for clostridium difficile diagnosticsSOMALOGIC INC·Filed 2014·Granted Jul 14, 2015·5 cites·12 claims
- 2985US6344321B1Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-metGILEAD SCIENCES INC·Filed 1999·Granted Feb 5, 2002·60 cites·3 claims
- 3085US5723594AHigh affinity PDGF nucleic acid ligandsNEXSTAR PHARMACEUTICALS INC·Filed 1996·Granted Mar 3, 1998·67 cites·3 claims
- 3184US7973050B2Enantiomeric compounds with antibacterial activityCRESTONE INC·Filed 2007·Granted Jul 5, 2011·5 cites·9 claims
- 3284US6962784B2Vascular endothelial growth factor (VEGF) nucleic acid ligand complexesGILEAD SCIENCES INC·Filed 2002·Granted Nov 8, 2005·13 cites·17 claims
- 3384US6677146B1Thermophilic polymerase III holoenzymeREPLIDYNE INC·Filed 2001·Granted Jan 13, 2004·20 cites·3 claims
- 3484US2025129373A1Oligonucleotides Comprising Modified NucleosidesSOMALOGIC OPERATING CO INC·Filed 2024·Application pending·0 cites
- 3582US12180482B2Oligonucleotides comprising modified nucleosidesSOMALOGIC OPERATING CO INC·Filed 2023·Granted Dec 31, 2024·0 cites·19 claims
- 3682US9410156B2Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditionsSOMALOGIC INC·Filed 2013·Granted Aug 9, 2016·4 cites·24 claims
- 3782US6696252B2High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)GILEAD SCIENCES INC·Filed 2001·Granted Feb 24, 2004·10 cites·9 claims
- 3882US5849479AHigh-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)NEXSTAR PHARMACEUTICALS INC·Filed 1994·Granted Dec 15, 1998·33 cites·6 claims
- 3982US5639868AHigh-affinity RNA ligands for basic fibroblast growth factorNEXSTAR PHARMACEUTICALS INC·Filed 1995·Granted Jun 17, 1997·46 cites·9 claims
- 4080US8895241B2Aptamers for clostridium difficile diagnosticsOCHSNER URS·Filed 2012·Granted Nov 25, 2014·5 cites·6 claims
- 4179US9695424B2PDGF and VEGF aptamers having improved stability and their use in treating PDGF and VEGF mediated diseases and disordersSOMALOGIC INC·Filed 2014·Granted Jul 4, 2017·3 cites·9 claims
- 4279US7196069B2High affinity RNA ligands of basic fibroblast growth factorGILEAD SCIENCES INC·Filed 2004·Granted Mar 27, 2007·4 cites·9 claims
- 4379US7153948B2High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)GILEAD SCIENCES INC·Filed 2003·Granted Dec 26, 2006·5 cites·1 claims
- 4478US9994857B2PDGF and VEGF aptamers having improved stability and their use in treating PDGF and VEGF mediated diseases and disordersSOMALOGIC INC·Filed 2017·Granted Jun 12, 2018·2 cites·3 claims
- 4578US8071737B2Nucleic acid ligand complexesGOLD LARRY·Filed 2009·Granted Dec 6, 2011·2 cites·1 claims
- 4678US7994192B2Substituted thienopyridone compounds with antibacterial activityCRESTONE INC·Filed 2007·Granted Aug 9, 2011·4 cites·6 claims
- 4778US5843732AMethod and apparatus for determining consensus secondary structures for nucleic acid sequencesNEXSTAR PHARMACEUTICALS INC·Filed 1995·Granted Dec 1, 1998·59 cites·20 claims
- 4876US7094535B2Nucleic acid ligands to integrinsGILEAD SCIENCES INC·Filed 2001·Granted Aug 22, 2006·4 cites·2 claims
- 4975US10544419B2PDGF and VEGF aptamers having improved stability and their use in treating PDGF and VEGF mediated diseases and disordersSOMALOGIC INC·Filed 2018·Granted Jan 28, 2020·1 cites·8 claims
- 5075US2023193287A1Nucleic Acid Compounds for Binding Growth Differentiation Factor 11SOMALOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 101 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Nebojsa Janjic files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →